GPI-1485 (Guilford).

Article Details

Citation
Copy to clipboard

Marshall VL, Grosset DG

GPI-1485 (Guilford).

Curr Opin Investig Drugs. 2004 Jan;5(1):107-12.

PubMed ID
14983983 [ View in PubMed
]
Abstract

GPI-1485 is a neuroimmunophilin ligand that binds to FK-506-binding proteins and is under development by Guilford for the potential treatment of erectile dysfunction following nerve injury during prostate resection and Parkinson's disease. In August 2002, phase II clinical trials investigating GPI-1485 for Parkinson's disease commenced, and in November 2003, further phase II trials commenced for post-prostatectomy erectile dysfunction.

DrugBank Data that Cites this Article

Drugs